Get to know the API Board of Directors.
Mr Peter R Robinson (Chairman)
B.Com, FAICD, Non-Executive Director

Director since 5 May 2000

Appointed Chairman 8 July 2003

Mr Robinson has held both executive and non-executive directorships for over 30 years. Mr Robinson also during this time has had extensive general management and chief executive officer experience in the pharmaceutical industry.

Other current listed company directorships:

  • Clover Corporation Limited
  • TPI Enterprises Ltd (listed ASX 10 August 2015)

Former listed company directorships in the past three years:

  • Washington H Soul Pattinson and Company Limited (appointed 1984, resigned 31 March 2015)
  • New Hope Corporation Limited (appointed August 1997, resigned 31 March 2015)
  • Exco Resources Limited (appointed November 2012, company de-listed January 2013)
Mr Robert D Millner
FAICD, Non-Executive Director

Director since 5 May 2000

Appointed Member of the Remuneration Committee on 2 October 2007

Appointed Member of the Nomination Committee on 15 August 2012

Mr Millner has had extensive management and public company experience across a number of industries.

Other current listed company directorships:

  • Brickworks Limited
  • BKI Investment Company Limited
  • Milton Corporation Limited
  • New Hope Corporation Limited
  • TPG Telecom Ltd
  • Washington H Soul Pattinson and Company Limted

Former listed company directorships in the past three years:

  • Exco Resources Limited (appointed November 2012, company de-listed January 2013)
Mr Richard Vincent (CEO & Managing Director)
Managing Director and Chief Executive Officer since 15 February 2017   Mr Vincent joined API in 2005 and is responsible for API’s pharmaceutical wholesaling business and IT. Mr Vincent also leads API’s manufacturing business in Auckland, New Zealand. He has held senior leadership roles in the healthcare industry for 17 years and has led a number of ERP and systems implementation programs. API’s retail and wholesale functions are also part of Mr Vincent’s responsibilities.
Ms Lee Ausburn
M.Pharm, B.Pharm, Dip.Hosp.Pharm, GAICD Independent Non-Executive Director

Director since 7 October 2008

Appointed member of the Audit and Risk Committee on 7 October 2008

Appointed member of the Nomination Committee on 15 August 2012 and appointed Chair on 8 April 2015

Ms Ausburn is a pharmacist with experience in retail and hospital pharmacy and in academia. She had a long career in the pharmaceutical industry with Merck Sharp and Dohme (Australia) Pty Ltd and was previously Vice President, Asia, for Merck and Co Inc with responsibility for the company’s operations across Asia.

Ms Ausburn is also President, Pharmacy Faculty Foundation, University of Sydney and is a former board member of the Clinical Excellence Commission and Agency for Clinical Innovation, NSW Health.

Other current listed company directorships:

  • NIB Holdings Limited
  • Somnomed Limited
Mr Gerard J Masters
Independent Non-Executive Director

Director since 7 September 2010

Appointed Member of the Nomination Committee on 15 August 2012

Appointed Member and Chair of the Remuneration Committee on 30 January 2014

Mr Masters has had extensive experience in retailing. Until his resignation in early 2006, he spent more than 33 years with the Coles Myer Group. This included a 10 year period as Managing Director of Bi Lo, Coles and then the total Supermarkets Group which was Coles Myer’s largest and most profitable business. His most recent role, until his resignation in 2009, was as the Managing Director and CEO of The Reject Shop Limited.

Mr Kenneth W Gunderson-Briggs
B. Bus, FCA, MAICD, Senior Independent Non-Executive Director

Director since 6 May 2014

Appointed Member of the Audit and Risk Committee on 6 May 2014 and appointed Chair on 25 January 2017

Appointed Member of the Remuneration Committee on 8 April 2015

Appointed Senior Independent Director 2 September 2015

Mr Gunderson-Briggs is a Chartered Accountant, Registered Company Auditor and Public Company Director, with broad experience in the finance and retail franchise sectors.

Mr Gunderson-Briggs has been Chairman of Glenaeon Rudolf Steiner School Limited since 2013, having been a Director on the Board since 2009.

Other current listed company directorships:

  • Harvey Norman Holdings Limited